Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Bristol-myers Squibb drug EVOTAZ appeared first on…
Annual Drug Patent Expirations for ANNOVERA Annovera is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Therapeuticsmd Inc drug ANNOVERA appeared first on…
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Annual Drug Patent Expirations for BEVYXXA Bevyxxa is a drug marketed by Portola Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Portola Pharms drug BEVYXXA appeared first on D…
New patent expiration for Portola Pharms drug BEVYXXA Read Post »
This chart shows the drugs with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Singa…
Which pharmaceutical drugs have the most drug patents in Singapore? Read Post »
Annual Drug Patent Expirations for XYWAV Xywav is a drug marketed by Jazz and is included in one NDA. It is available from one supplier. The generic ingredient in XYWAV…
The post New patent for JAZZ drug XYWAV appeared first on DrugPatentWatch – Make B…
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Tolmar drug FENSOLVI KIT appeared first on DrugP…
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are six patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugPat…
Annual Drug Patent Expirations for WYNZORA Wynzora is a drug marketed by MC2 and is included in one NDA. The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. Additional details…
The post New patent for MC2 drug WYNZORA appear…
Annual Drug Patent Expirations for BREZTRI+AEROSPHERE Breztri Aerosphere is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. The generic ingredient…
The post New patent for Astrazeneca Ab drug BREZTRI AER…
New patent for Astrazeneca Ab drug BREZTRI AEROSPHERE Read Post »